Exemestane Tablet
Product Images NDC 69097-316

4 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Exemestane (NDC 69097-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Exemestane (Api Structure)

Structure Of Exemestane (Api Structure)
Chemical structure of exemestane, showing its molecular framework with multiple rings, hydroxyl groups, and substituents as depicted in the diagram.*
FDA Label Image

Image (Edfb31df 8ec2 440f 84ca 5e86c10bbc46 02)

Image (Edfb31df 8ec2 440f 84ca 5e86c10bbc46 02)
A Kaplan-Meier survival curve comparing disease-free survival between patients treated with exemestane and tamoxifen over a duration of up to 70 months. The vertical axis shows the proportion surviving, while the horizontal axis indicates months. The exemestane group (solid red line) demonstrates a higher survival proportion than the tamoxifen group (dashed blue line). The graph includes hazard ratio (HR 0.69, 95% CI 0.58-0.82) and p-value (0.00003) for the comparison.*
FDA Label Image

Time To Tumor Progression In The Comparative Study Of Postmenopausal Women With Advanced Breast Cancer Whose Disease Had Progressed After Tamoxifen Therapy (Edfb31df 8ec2 440f 84ca 5e86c10bbc46 03)

Time To Tumor Progression In The Comparative Study Of Postmenopausal Women With Advanced Breast Cancer Whose Disease Had Progressed After Tamoxifen Therapy (Edfb31df 8ec2 440f 84ca 5e86c10bbc46 03)
A line graph comparing the probability over time (in weeks) for two groups receiving Exemestane and Megestrol Acetate. The graph shows survival or event-free probability decreasing over a timeframe extending to approximately 140 weeks, with separate lines depicting each treatment group.*
FDA Label Image

Exemestane 25mg Lable (Exemestane25mglable)

Exemestane 25mg Lable (Exemestane25mglable)
EXEMESTANE Tablets, USP 25 mg oral tablets, labeled for 30 tablets per bottle. The label includes storage instructions, manufacturer Cipla USA Inc., and the NDC 69097-316. The tablet strength and quantity are clearly indicated on the front of the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.